Investigation of a 3 oz Water Protocol on Patients With Tracheostomies
1 other identifier
observational
80
1 country
1
Brief Summary
Examining the validity of a novel 3 oz protocol in patients with tracheostomies as compared to the gold standard of instrumental swallow assessments (Flexible Endoscopic Evaluation of the Swallow or Modified Barium Swallow Study).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2023
CompletedFirst Posted
Study publicly available on registry
November 7, 2023
CompletedStudy Start
First participant enrolled
May 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
September 8, 2025
September 1, 2025
3.4 years
November 1, 2023
September 5, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Swallow screen
Swallow screen measured as pass/fail for presence or absence of aspiration
End of participation study within 7 days of enrollment
Penetration Aspiration Scale Score
The penetration aspiration scale (PAS) is a validated measure used by trained blinded clinicians to assign ratings of safety to swallowing bolus trials. The PAS is an 8-point, equal-appearing interval scale (8 being best; 1 being worst) to describe penetration and aspiration events. Scores are determined primarily by the depth to which material passes in the airway and by whether or not material entering the airway is expelled. Higher scores indicate better health outcomes.
End of participation study within 7 days of enrollment
Study Arms (1)
Patients with Tracheostomies
Patients with openings in their airways (i.e. tracheostomies)
Interventions
Patient will consume 3 oz of water continuously without stopping and then will be monitored for one minute post completion. Patient will complete this twice in the same session.
Eligibility Criteria
Patients with a tracheostomy (dysphagia).
You may qualify if:
- Has a tracheostomy
- Able to remain alert for testing
- Not on a modified diet for pre-existing dysphagia
- No head of bed restrictions
- Not NPO by physician for any reason other than possible dysphagia
- At least 18 years old
You may not qualify if:
- Does not have a tracheostomy
- Unable to remain alert for testing
- On a modified diet due to pre-existing dysphagia
- Head of bed restrictions for greater than or equal to 30 degrees
- NPO by physician for reasons other than possible dysphagia
- Less than 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mount Sinai Hospital
New York, New York, 10029, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Miguel Escalon
Icahn School of Medicine at Mount Sinai
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 1, 2023
First Posted
November 7, 2023
Study Start
May 6, 2024
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
September 8, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Beginning 3 months and ending 5 years following article publication.
- Access Criteria
- Researchers who provide a methodologically sound proposal. To achieve aims in the approved proposal. Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Proposals should be directed to miguel.escalon@mountsinai.org.
All of the individual participant data collected during the trial, after deidentification.